FDA Approves Inhalable Diabetes Drug Afrezza

June 27, 2014 8:12 PM

8 0

The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals.

The FDA cleared MannKind Corp.'s drug Afrezza, a fast-acting form of insulin, for adults with the most common form of diabetes that affects more than 25 million Americans. The approval decision comes more than three years after the agency first asked MannKind to run additional clinical studies on th...

Also read: McKesson to Pay $150 Million for Failing to Report ‘Suspicious’ Drug Orders

Read more

To category page

Loading...